BIO Comments on China's Proposed Rules for the Implementation of Regulations on Management of Human Genetic Resources
April 21, 2022
The Biotechnology Innovation Organization (BIO) welcomes the opportunity to provide comments on the proposed Rules for the Implementation of Regulations on Management of Human Genetic Resources (HGR). BIO acknowledges the efforts of the Division of Science and Technology for Social Development of the Ministry of Science and Technology (MOST) to further develop rules on the management of HGR to further harmonize existing rules with the recently enacted Biosecurity Law.
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
The Biotechnology Innovation Organization (BIO) welcomes the opportunity to provide comments on the proposed Rules for the Implementation of Regulations on Management of Human Genetic Resources (HGR). BIO acknowledges the efforts of the Division of Science and Technology for Social Development of the Ministry of Science and Technology (MOST) to further develop rules on the management of HGR to further harmonize existing rules with the recently enacted Biosecurity Law.